Annual EBITDA
-$7.68 M
+$3.25 M+29.74%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual EBITDA is -$7.68 million, with the most recent change of +$3.25 million (+29.74%) on December 31, 2023.
- During the last 3 years, TENX annual EBITDA has risen by +$2.06 million (+21.12%).
- TENX annual EBITDA is now -859.89% below its all-time high of -$800.00 thousand, reached on April 30, 1999.
Performance
TENX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.95 M
-$387.70 K-10.87%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly EBITDA is -$3.95 million, with the most recent change of -$387.70 thousand (-10.87%) on September 30, 2024.
- Over the past year, TENX quarterly EBITDA has dropped by -$163.30 thousand (-4.31%).
- TENX quarterly EBITDA is now -1068.22% below its all-time high of $408.40 thousand, reached on October 31, 2005.
Performance
TENX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$14.53 M
-$1.99 M-15.85%
September 30, 2024
Summary
- As of February 8, 2025, TENX TTM EBITDA is -$14.53 million, with the most recent change of -$1.99 million (-15.85%) on September 30, 2024.
- Over the past year, TENX TTM EBITDA has dropped by -$4.46 million (-44.27%).
Performance
TENX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TENX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.7% | -4.3% | -44.3% |
| 3 y3 years | +21.1% | -260.7% | -83.9% |
| 5 y5 years | -11.6% | -260.7% | -83.9% |
TENX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.3% | -260.7% | at low | -108.2% | +55.1% |
| 5 y | 5-year | at high | +76.3% | -260.7% | +83.3% | -108.2% | +55.1% |
| alltime | all time | -859.9% | +76.3% | -1068.2% | +83.3% | <-9999.0% | +55.1% |
Tenax Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.95 M(+10.9%) | -$14.53 M(+15.9%) |
| Jun 2024 | - | -$3.57 M(-5.9%) | -$12.54 M(+24.5%) |
| Mar 2024 | - | -$3.79 M(+17.8%) | -$10.07 M(+31.2%) |
| Dec 2023 | -$7.68 M(-29.7%) | -$3.22 M(+63.7%) | -$7.68 M(+10.0%) |
| Sep 2023 | - | -$1.97 M(+79.3%) | -$6.98 M(-11.7%) |
| Jun 2023 | - | -$1.10 M(-21.6%) | -$7.90 M(-18.0%) |
| Mar 2023 | - | -$1.40 M(-44.5%) | -$9.64 M(-11.8%) |
| Dec 2022 | -$10.93 M(-66.2%) | -$2.52 M(-12.7%) | -$10.93 M(-5.7%) |
| Sep 2022 | - | -$2.89 M(+2.0%) | -$11.59 M(-7.1%) |
| Jun 2022 | - | -$2.83 M(+5.2%) | -$12.48 M(+10.1%) |
| Mar 2022 | - | -$2.69 M(-15.5%) | -$11.34 M(-65.0%) |
| Dec 2021 | -$32.36 M(+232.5%) | -$3.18 M(-15.6%) | -$32.36 M(+1.2%) |
| Sep 2021 | - | -$3.77 M(+123.1%) | -$31.98 M(+5.2%) |
| Jun 2021 | - | -$1.69 M(-92.9%) | -$30.40 M(-1.4%) |
| Mar 2021 | - | -$23.72 M(+747.1%) | -$30.83 M(+216.6%) |
| Dec 2020 | -$9.73 M(+17.5%) | -$2.80 M(+27.8%) | -$9.73 M(+0.4%) |
| Sep 2020 | - | -$2.19 M(+3.5%) | -$9.70 M(-0.1%) |
| Jun 2020 | - | -$2.12 M(-19.4%) | -$9.71 M(+4.1%) |
| Mar 2020 | - | -$2.63 M(-5.0%) | -$9.32 M(+11.9%) |
| Dec 2019 | -$8.29 M(+20.4%) | -$2.76 M(+25.8%) | -$8.33 M(+6.9%) |
| Sep 2019 | - | -$2.20 M(+26.6%) | -$7.79 M(+9.0%) |
| Jun 2019 | - | -$1.73 M(+6.1%) | -$7.15 M(-2.1%) |
| Mar 2019 | - | -$1.64 M(-26.5%) | -$7.30 M(+6.0%) |
| Dec 2018 | -$6.88 M(-25.1%) | -$2.23 M(+43.4%) | -$6.88 M(+14.0%) |
| Sep 2018 | - | -$1.55 M(-17.7%) | -$6.04 M(+4.2%) |
| Jun 2018 | - | -$1.89 M(+54.5%) | -$5.79 M(-16.3%) |
| Mar 2018 | - | -$1.22 M(-11.5%) | -$6.92 M(-24.7%) |
| Dec 2017 | -$9.19 M(-52.5%) | -$1.38 M(+5.5%) | -$9.19 M(-25.4%) |
| Sep 2017 | - | -$1.31 M(-56.6%) | -$12.32 M(-20.6%) |
| Jun 2017 | - | -$3.01 M(-13.9%) | -$15.50 M(-9.6%) |
| Mar 2017 | - | -$3.49 M(-22.4%) | -$17.16 M(-11.4%) |
| Dec 2016 | -$19.37 M(+93.0%) | -$4.50 M(+0.2%) | -$19.37 M(+30.3%) |
| Sep 2016 | - | -$4.50 M(-3.7%) | -$14.86 M(-11.5%) |
| Jun 2016 | - | -$4.67 M(-18.1%) | -$16.80 M(+10.9%) |
| Mar 2016 | - | -$5.70 M(+62.3%) | -$15.15 M(-24.7%) |
| Dec 2015 | -$10.04 M(-27.7%) | - | - |
| Oct 2015 | - | -$3.51 M(+20.3%) | -$20.14 M(+21.1%) |
| Sep 2015 | - | -$2.92 M(-3.3%) | -$16.62 M(-6.2%) |
| Jul 2015 | - | -$3.02 M(-39.0%) | -$17.72 M(+5.6%) |
| Apr 2015 | -$13.88 M(-19.2%) | -$4.95 M(+70.6%) | -$16.79 M(+41.8%) |
| Mar 2015 | - | -$2.90 M(+2.5%) | -$11.84 M(-38.5%) |
| Jan 2015 | - | -$2.83 M(-29.5%) | -$19.24 M(-2.1%) |
| Oct 2014 | - | -$4.02 M(+92.5%) | -$19.65 M(+11.0%) |
| Jul 2014 | - | -$2.09 M(-79.8%) | -$17.71 M(+3.1%) |
| Apr 2014 | -$17.18 M(+241.6%) | -$10.31 M(+217.6%) | -$17.18 M(+112.8%) |
| Jan 2014 | - | -$3.24 M(+56.2%) | -$8.07 M(+26.5%) |
| Oct 2013 | - | -$2.08 M(+33.8%) | -$6.38 M(+28.7%) |
| Jul 2013 | - | -$1.55 M(+29.6%) | -$4.96 M(-1.4%) |
| Apr 2013 | -$5.03 M(-37.9%) | -$1.20 M(-22.9%) | -$5.03 M(-10.9%) |
| Jan 2013 | - | -$1.55 M(+138.0%) | -$5.64 M(-5.9%) |
| Oct 2012 | - | -$653.10 K(-59.8%) | -$6.00 M(-18.7%) |
| Jul 2012 | - | -$1.62 M(-10.4%) | -$7.38 M(-8.9%) |
| Apr 2012 | -$8.09 M | -$1.81 M(-5.1%) | -$8.09 M(-6.5%) |
| Jan 2012 | - | -$1.91 M(-6.0%) | -$8.65 M(-8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2011 | - | -$2.03 M(-13.3%) | -$9.43 M(+0.3%) |
| Jul 2011 | - | -$2.34 M(-1.2%) | -$9.40 M(-5.3%) |
| Apr 2011 | -$9.95 M(-1.4%) | -$2.37 M(-11.9%) | -$9.93 M(-1.8%) |
| Jan 2011 | - | -$2.69 M(+34.6%) | -$10.11 M(-0.3%) |
| Oct 2010 | - | -$2.00 M(-30.3%) | -$10.14 M(-5.2%) |
| Jul 2010 | - | -$2.87 M(+12.4%) | -$10.69 M(+6.0%) |
| Apr 2010 | -$10.09 M(+17.6%) | -$2.55 M(-6.0%) | -$10.09 M(+4.0%) |
| Jan 2010 | - | -$2.72 M(+6.2%) | -$9.70 M(+22.7%) |
| Oct 2009 | - | -$2.56 M(+12.9%) | -$7.91 M(+3.0%) |
| Jul 2009 | - | -$2.26 M(+4.5%) | -$7.68 M(-9.7%) |
| Apr 2009 | -$8.58 M(+203.2%) | -$2.17 M(+134.6%) | -$8.51 M(+10.8%) |
| Jan 2009 | - | -$923.40 K(-60.3%) | -$7.68 M(+0.9%) |
| Oct 2008 | - | -$2.33 M(-24.8%) | -$7.61 M(+36.7%) |
| Jul 2008 | - | -$3.09 M(+131.8%) | -$5.57 M(+97.3%) |
| Apr 2008 | -$2.83 M(+74.7%) | -$1.33 M(+55.6%) | -$2.82 M(+50.7%) |
| Jan 2008 | - | -$858.10 K(+203.8%) | -$1.87 M(+77.9%) |
| Oct 2007 | - | -$282.50 K(-18.5%) | -$1.05 M(+28.8%) |
| Jul 2007 | - | -$346.70 K(-10.1%) | -$817.70 K(+9.2%) |
| Apr 2007 | -$1.62 M(-26.9%) | -$385.50 K(+911.8%) | -$749.10 K(-14.8%) |
| Jan 2007 | - | -$38.10 K(-19.6%) | -$879.40 K(-27.6%) |
| Oct 2006 | - | -$47.40 K(-83.0%) | -$1.21 M(+60.1%) |
| Jul 2006 | - | -$278.10 K(-46.1%) | -$758.90 K(-26.6%) |
| Apr 2006 | -$2.22 M(-8.4%) | -$515.80 K(+38.1%) | -$1.03 M(-1.4%) |
| Jan 2006 | - | -$373.40 K(-191.4%) | -$1.05 M(-33.1%) |
| Oct 2005 | - | $408.40 K(-173.9%) | -$1.57 M(-37.2%) |
| Jul 2005 | - | -$552.80 K(+4.1%) | -$2.50 M(+5.2%) |
| Apr 2005 | -$2.42 M(+13.8%) | -$530.80 K(-40.6%) | -$2.37 M(+1.8%) |
| Jan 2005 | - | -$893.30 K(+71.0%) | -$2.33 M(+5.3%) |
| Oct 2004 | - | -$522.30 K(+21.9%) | -$2.21 M(+4.1%) |
| Jul 2004 | - | -$428.30 K(-12.5%) | -$2.13 M(+0.1%) |
| Apr 2004 | -$2.13 M(-0.5%) | -$489.40 K(-36.8%) | -$2.13 M(+9.3%) |
| Jan 2004 | - | -$774.90 K(+78.5%) | -$1.95 M(+20.8%) |
| Oct 2003 | - | -$434.20 K(+1.7%) | -$1.61 M(-26.2%) |
| Jul 2003 | - | -$427.00 K(+38.2%) | -$2.18 M(+2.1%) |
| Apr 2003 | -$2.14 M(-38.9%) | -$309.00 K(-29.7%) | -$2.14 M(-44.0%) |
| Jan 2003 | - | -$439.60 K(-56.3%) | -$3.81 M(+13.5%) |
| Oct 2002 | - | -$1.01 M(+162.6%) | -$3.36 M(+16.5%) |
| Jul 2002 | - | -$382.70 K(-80.7%) | -$2.88 M(-5.1%) |
| Apr 2002 | -$3.49 M(+81.0%) | -$1.99 M(<-9900.0%) | -$3.04 M(+89.4%) |
| Jan 2002 | - | $14.50 K(-102.7%) | -$1.60 M(-4.3%) |
| Oct 2001 | - | -$529.50 K(-1.5%) | -$1.68 M(-2.3%) |
| Jul 2001 | - | -$537.80 K(-2.5%) | -$1.72 M(+13.3%) |
| Apr 2001 | -$1.93 M(+125.1%) | -$551.40 K(+860.6%) | -$1.52 M(+10.2%) |
| Jan 2001 | - | -$57.40 K(-89.9%) | -$1.38 M(-3.0%) |
| Oct 2000 | - | -$569.30 K(+68.9%) | -$1.42 M(+35.2%) |
| Jul 2000 | - | -$337.00 K(-18.1%) | -$1.05 M(+47.4%) |
| Apr 2000 | -$857.60 K(+7.2%) | -$411.60 K(+311.6%) | -$711.60 K(+137.2%) |
| Jan 2000 | - | -$100.00 K(-50.0%) | -$300.00 K(+50.0%) |
| Oct 1999 | - | -$200.00 K(<-9900.0%) | -$200.00 K(<-9900.0%) |
| Jul 1999 | - | $0.00 | $0.00 |
| Apr 1999 | -$800.00 K(-32.5%) | - | - |
| Apr 1998 | -$1.19 M(-34.7%) | - | - |
| Apr 1997 | -$1.82 M(-19.7%) | - | - |
| Apr 1996 | -$2.26 M | - | - |
FAQ
- What is Tenax Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Tenax Therapeutics?
- What is Tenax Therapeutics annual EBITDA year-on-year change?
- What is Tenax Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly EBITDA year-on-year change?
- What is Tenax Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Tenax Therapeutics?
- What is Tenax Therapeutics TTM EBITDA year-on-year change?
What is Tenax Therapeutics annual EBITDA?
The current annual EBITDA of TENX is -$7.68 M
What is the all time high annual EBITDA for Tenax Therapeutics?
Tenax Therapeutics all-time high annual EBITDA is -$800.00 K
What is Tenax Therapeutics annual EBITDA year-on-year change?
Over the past year, TENX annual EBITDA has changed by +$3.25 M (+29.74%)
What is Tenax Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TENX is -$3.95 M
What is the all time high quarterly EBITDA for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly EBITDA is $408.40 K
What is Tenax Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TENX quarterly EBITDA has changed by -$163.30 K (-4.31%)
What is Tenax Therapeutics TTM EBITDA?
The current TTM EBITDA of TENX is -$14.53 M
What is the all time high TTM EBITDA for Tenax Therapeutics?
Tenax Therapeutics all-time high TTM EBITDA is $0.00
What is Tenax Therapeutics TTM EBITDA year-on-year change?
Over the past year, TENX TTM EBITDA has changed by -$4.46 M (-44.27%)